Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 3
1999 2
2000 4
2001 6
2002 5
2003 8
2004 5
2005 8
2006 4
2007 2
2008 3
2009 4
2010 9
2011 11
2012 2
2013 8
2014 6
2015 13
2016 4
2017 12
2018 10
2019 5
2020 17
2021 12
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, Assenat E, Tacher V, Robert C, Terroir-Cassou-Mounat M, Mariano-Goulart D, Amaddeo G, Palard X, Hollebecque A, Kafrouni M, Regnault H, Boudjema K, Grimaldi S, Fourcade M, Kobeiter H, Vibert E, Le Sourd S, Piron L, Sommacale D, Laffont S, Campillo-Gimenez B, Rolland Y; DOSISPHERE-01 Study Group. Garin E, et al. Among authors: kobeiter h. Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33166497 Free article. Clinical Trial.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Bringing Interventional Radiology to Mars!
Vidal V, Boyer L, Luciani A; SFR-CNES collaborative group. Vidal V, et al. Cardiovasc Intervent Radiol. 2023 Apr;46(4):425-427. doi: 10.1007/s00270-023-03392-3. Epub 2023 Mar 14. Cardiovasc Intervent Radiol. 2023. PMID: 36918421
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial.
Sapoval M, Thiounn N, Descazeaud A, Déan C, Ruffion A, Pagnoux G, Duarte RC, Robert G, Petitpierre F, Karsenty G, Vidal V, Murez T, Vernhet-Kovacsik H, de la Taille A, Kobeiter H, Mathieu R, Heautot JF, Droupy S, Frandon J, Barry Delongchamps N, Korb-Savoldelli V, Durand-Zaleski I, Pereira H, Chatellier G; PARTEM study group. Sapoval M, et al. Among authors: kobeiter h. Lancet Reg Health Eur. 2023 Jun 26;31:100672. doi: 10.1016/j.lanepe.2023.100672. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37415648 Free PMC article.
The Use of Re-entry Devices in Aortoiliac Occlusive Disease.
Pescatori LC, Tacher V, Kobeiter H. Pescatori LC, et al. Among authors: kobeiter h. Front Cardiovasc Med. 2020 Aug 25;7:144. doi: 10.3389/fcvm.2020.00144. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33062643 Free PMC article. Review.
[Hepatic pseudolesions].
Mathieu D, Luciani A, Achab A, Zegai B, Bouanane M, Kobeiter H. Mathieu D, et al. Among authors: kobeiter h. Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B158-66. Gastroenterol Clin Biol. 2001. PMID: 11449157 Free article. Review. French. No abstract available.
Ruptured visceral artery aneurysms.
Chiaradia M, Novelli L, Deux JF, Tacher V, Mayer J, You K, Djabbari M, Luciani A, Rahmouni A, Kobeiter H. Chiaradia M, et al. Among authors: kobeiter h. Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):797-806. doi: 10.1016/j.diii.2015.03.012. Epub 2015 Jun 6. Diagn Interv Imaging. 2015. PMID: 26054246 Free article. Review.
Delayed complications following EVAR.
Becquemin JP, Allaire E, Desgranges P, Kobeiter H. Becquemin JP, et al. Among authors: kobeiter h. Tech Vasc Interv Radiol. 2005 Mar;8(1):30-40. doi: 10.1053/j.tvir.2005.03.011. Tech Vasc Interv Radiol. 2005. PMID: 16098935 Review.
153 results